Trial intelligence / Profile preview

Valproate vs Risperidone in Young Children with Bipolar Disorder

NCT02456454Phase 3Completed

Sponsor
Nationwide Children's Hospital
Start
Jan 2006
Primary completion
Jun 2010
Modality
Small Molecules
01

Overview

A Phase 3 trial of risperidone, valproic acid in bipolar disorder (BD), sponsored by Nationwide Children's Hospital. Started Jan 2006; status: completed.

02

Drugs

risperidonevalproic acid
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT02456454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02456454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call